/Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
Citation Map
The articles shown here are a subset.See the full list of articles below.

Citing (0)

Cited By (0)